医疗保健供应商优先考虑AI合作伙伴关系
医疗保健供应商越来越多地寻求与第三方供应商合作，61%的组织倾向于这种定制化AI解决方案而非内部开发。美国食品药品监督管理局已批准1300多种AI医疗设备，其中超过一半在过去三年中获得批准。然而，调查显示，77%的技术领导者认为不成熟的AI工具是采用的主要障碍。
Health care providers are shifting their AI strategy toward partnerships. A McKinsey study found 61% of health care organizations intend to partner with third-party vendors to develop customized generative AI solutions, favoring collaboration over in-house building or off-the-shelf products. This strategy aims to address specific clinical and operational needs while avoiding implementation failures common in complex health care environments.
Adoption faces significant hurdles despite rising AI utilization. The FDA reports approval of over 1,300 AI-enabled medical devices, with more than 50% authorized in the past three years. However, 77% of surveyed technology leaders cite immature AI tools as a major barrier to adoption. Furthermore, 72% of leaders prioritize reducing caregiver burden, while 53% focus on workflow efficiency, highlighting a demand for administrative tools over purely clinical applications.